Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 15, 2009
J Am Soc Nephrol 20: 2389-2402, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008040435

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2008040435v1
20/11/2389    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Bastos, A. P.
Right arrow Articles by Onuchic, L. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bastos, A. P.
Right arrow Articles by Onuchic, L. F.
Related Collections
Right arrowRelated Article

BASIC RESEARCH

Pkd1 Haploinsufficiency Increases Renal Damage and Induces Microcyst Formation following Ischemia/Reperfusion

Ana P. Bastos*, Klaus Piontek{dagger}, Ana M. Silva{ddagger}, Dino Martini§, Luis F. Menezes{dagger}, Jonathan M. Fonseca*, Ivone I. Fonseca*, Gregory G. Germino{dagger} and Luiz F. Onuchic*

*Department of Medicine, Division of Nephrology, and
{ddagger}Department of Pathology, University of São Paulo School of Medicine, São Paulo, Brazil;
{dagger}Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
§Division of Pathology, Beneficência Portuguesa Hospital, São Paulo, Brazil

Correspondence: Dr. Luiz F. Onuchic, Avenida Dr. Arnaldo, 455, Sala 4304, São Paulo, SP 01246-903, Brazil. Phone: 55-11-3061-8399; Fax: 55-11-3061-8361; E-mail: lonuchic{at}lim12.fm.usp.br

Received for publication April 29, 2008. Accepted for publication August 6, 2009.

Mutations in PKD1 cause the majority of cases of autosomal dominant polycystic kidney disease (ADPKD). Because polycystin 1 modulates cell proliferation, cell differentiation, and apoptosis, its lower biologic activity observed in ADPKD might influence the degree of injury after renal ischemia/reperfusion. We induced renal ischemia/reperfusion in 10- to 12-wk-old male noncystic Pkd1+/– and wild-type mice. Compared with wild-type mice, heterozygous mice had higher fractional excretions of sodium and potassium and higher serum creatinine after 48 h. In addition, in heterozygous mice, also cortical damage, rates of apoptosis, and inflammatory infiltration into the interstitium at time points out to 14 d after injury all increased, as well as cell proliferation at 48 h and 7 d. The mRNA and protein expression of p21 was lower in heterozygous mice than wild-type mice at 48 h. After 6 wk, we observed dilated tubules, microcysts, and increased renal fibrosis in heterozygotes. The early mortality of heterozygotes was significantly higher than that of wild-type mice when we extended the duration of ischemia from 32 to 35 min. In conclusion, ischemia/reperfusion induces a more severe injury in kidneys of Pkd1-haploinsufficient mice, a process that apparently depends on a relative deficiency of p21 activity, tubular dilation, and microcyst formation. These data suggest the possibility that humans with ADPKD from PKD1 mutations may be at greater risk for damage from renal ischemia/reperfusion injury.


Related Article

This Month's Highlights
J. Am. Soc. Nephrol. 2009 20: A12. [Full Text] [PDF]






HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP